Free Daily Podcast Summary
DoctoRx Unscripted: Daily Summaries Delivered
by Bristol Myers Squibb
Welcome to DoctoRx Unscripted — where doctors shaping the next chapter of patient care come together for raw, real, and rigorously scientific conversations at the heart of medicine. Hosted by Dr. Tania Small, SVP of Global Medical Affairs — a physician who has dedicated her career to turning breakthrough science into real-world patient impact. In each episode, Dr. Small sits down with the world’s leading minds in medicine to dive into the breakthroughs, surface the unspoken realities, and tackle the real-world challenges shaping tomorrow’s standard of care. No soundbites. No scripts. Just evidence-based, peer-to-peer conversations that challenge thinking, ignite innovation, and equip you with insights to transform your own practice. So whether you’re in the clinic, the lab, or the boardroom — join us to rewrite patient care. Unscripted. Unfiltered. Unapologetic.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Sep 22, 202626 min
Beyond the Tumor: From Evidence to Action – Part 2
Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for Part 2 of this DoctoRx Unscripted conversation exploring how biology-based behavior change is redefining cancer care. In Part 2, Dr. Small hosts Arianna Huffington, Founder and CEO of Thrive Global, and Chris Boerner, Board Chair and CEO of Bristol Myers Squibb, for a candid discussion on moving beyond treating the tumor to delivering true whole-person care. Together, they explore: How everyday factors, like sleep, stress, movement, and social connection, impact cancer care Simple steps to reinforce healthier daily routines Why lifestyle changes remain critical alongside medical therapies How pharma leaders can integrate behavioral metrics into clinical trials Strategies to overcome healthcare disparities and expand access to behavioral health tools Medicines and healthy behaviors achieve more together than either can alone. Tune in to see why placing the patient at the center of oncology care can drive better long-term outcomes.
- Sep 22, 202653 min
Beyond the Tumor: From Biology to Behavior – Part 1
Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for Part 1 of a timely DoctoRx Unscripted conversation with Dr. Neil Iyengar, board-certified medical oncologist and Director of Survivorship Services at Winship Cancer Institute of Emory University. Together, they examine how metabolism, body composition, the gut microbiome, stress, and sleep influence cancer risk, treatment response, and long-term survivorship. In this episode, Dr. Small and Dr. Iyengar discuss: Why muscle-to-fat ratio matters more than BMI for health and cancer risk The connection between gut health, fiber, and cancer treatment success What new research reveals about GLP-1s in oncology How clinicians can make tailored exercise and nutrition accessible to every patient Learn how targeted lifestyle interventions pair with precision oncology.
- May 20, 202644 min
Lung Cancer – No Longer the Disease We Once Thought It Was
Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a forward-looking episode of DoctoRx Unscripted, featuring leading thoracic oncologists Dr. Christine Lovly and Dr. Nate Pennell. Together, they examine innovations redefining what’s possible for patients with lung cancer: Biomarker-driven therapy and molecular profiling; Liquid biopsy and ctDNA testing; AI-assisted detection and radiomics; and Next-generation immunotherapies, including bispecifics, T-cell engagers, and personalized vaccines. They also share their perspectives on a critical challenge: translating scientific progress into real-world impact by expanding access and closing gaps in care. If you're working to advance oncology care—or interested in deepening your understanding of what’s shaping its future—this is a conversation you don’t want to miss.
- Feb 25, 202638 min
Part 3 - Hypertrophic Cardiomyopathy: Hidden in Plain Sight
Part 3 - The Movement Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a special edition of DoctoRx Unscripted, focused on hypertrophic cardiomyopathy (HCM)—one of the most common inherited cardiac diseases and one of the most frequently missed. In Part 3, Dr. Small sits down with patient advocate Lisa Salberg, founder of the Hypertrophic Cardiomyopathy Association (HCMA), to explore how a personal diagnosis evolved into a global movement—helping to establish more than 60 Centers of Excellence around the world. The conversation reinforces why embedding the patient voice early is essential to advancing cardiovascular medicine.
- Feb 25, 202653 min
Part 2 - Hypertrophic Cardiomyopathy: Hidden in Plain Sight
Part 2 - The Shift Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a special edition of DoctoRx Unscripted, focused on hypertrophic cardiomyopathy (HCM)—one of the most common inherited cardiac diseases and one of the most frequently missed. In Part 2, Dr. Small welcomes HCM expert Dr. Matthew Martinez and leading cardiologist Dr. Nani Bhalla. Together, they examine why HCM has historically been so difficult to detect—and what has changed in recent years to begin altering that trajectory. The discussion explores how earlier recognition, paired with more precise and individualized treatment decisions, can change outcomes in meaningful and lasting ways.
- Feb 25, 202626 min
Part 1 - Hypertrophic Cardiomyopathy: Hidden in Plain Sight
Part 1 - The Moment Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a special edition of DoctoRx Unscripted, focused on hypertrophic cardiomyopathy (HCM)—one of the most common inherited cardiac diseases and one of the most frequently missed. In Part 1, NFL tight end Tommy Sweeney shares his experience being diagnosed with HCM. He reflects on his personal journey— from diagnosis and treatment decision making to his return to the NFL with his condition appropriately treated and well managed. His story underscores a sobering reality: HCM can remain undetected even in individuals who receive frequent medical screenings, like elite athletes.
- Dec 3, 202535 min
Part 2 - Myeloma: The New Playbook
Highlights include: • Early detection and the potential of screening studies like PROMISE and iStopMM • Modifiable risk factors—how diet, exercise, and inflammation shape disease and outcomes • Emerging therapies on the horizon • Why “down with dex” and other old beliefs deserve retirement • The personal “why” behind every advance in myeloma care About the Experts Dr. Paul Richardson Dr. Paul Richardson is an internationally recognized visionary in hematology and oncology whose trailblazing research at Dana-Farber Cancer Institute and Harvard Medical School has driven therapeutic revolutions in multiple myeloma, transforming patient outcomes and defining today’s standards of care. In addition to his involvement in the approval of nearly every major therapy for the disease over the past two decades, he is also one of the most prolific and cited experts in the field, with nearly 500 original articles and 400 reviews. Dr. Richardson is a paid consultant for BMS. Dr. Joseph Mikhael Dr. Joseph Mikhael has revolutionized and broadened access to world-class myeloma care globally through his pioneering leadership at TGen and the International Myeloma Foundation and as principal investigator of numerous groundbreaking clinical trials, setting new benchmarks in innovation, impact, and equity. Celebrated as a dynamic champion for underserved communities, an award-winning educator, and a masterful communicator, Dr. Mikhael has authored over 150 influential scientific articles and was recently recognized among America’s Top 100 Doctors for his transformational contributions to the field. Dr. Mikhael was not compensated for his participation. Dr. Mecide Gharibo Dr. Mecide Gharibo is an innovative hematology leader whose passion for transforming patient care extends from academic clinical expertise at Rutgers Cancer Institute to launching breakthrough therapies as Global Head of Hematology at Bristol Myers Squibb. Renowned for advancing life-saving treatments and optimizing patient access, Dr. Gharibo’s clinical excellence and senior pharmaceutical leadership have fueled medical innovation and set new standards for care through a proven record of successful therapy approvals. Dr. Gharibo is an employee of BMS.
- Dec 3, 202553 min
Part 1 - Myeloma: The New Playbook
Highlights include: • How MRD is reshaping drug development and accelerating innovation • The evolution of next-generation and targeted therapies with the goal of achieving deeper and more durable remissions • New thinking on “hit hard early” vs “save the best for last” treatment strategies • The impact of race, biology, and access on outcomes—and what’s changing that trajectory If you want to understand the science, urgency, and humanity driving today’s breakthroughs, this episode is your front-row seat to the bleeding edge of discovery. About the Experts Dr. Paul Richardson Dr. Paul Richardson is an internationally recognized visionary in hematology and oncology whose trailblazing research at Dana-Farber Cancer Institute and Harvard Medical School has driven therapeutic revolutions in multiple myeloma, transforming patient outcomes and defining today’s standards of care. In addition to his involvement in the approval of nearly every major therapy for the disease over the past two decades, he is also one of the most prolific and cited experts in the field, with nearly 500 original articles and 400 reviews. Dr. Richardson is a paid consultant for BMS. Dr. Joseph Mikhael Dr. Joseph Mikhael has revolutionized and broadened access to world-class myeloma care globally through his pioneering leadership at TGen and the International Myeloma Foundation and as principal investigator of numerous groundbreaking clinical trials, setting new benchmarks in innovation, impact, and equity. Celebrated as a dynamic champion for underserved communities, an award-winning educator, and a masterful communicator, Dr. Mikhael has authored over 150 influential scientific articles and was recently recognized among America’s Top 100 Doctors for his transformational contributions to the field. Dr. Mikhael was not compensated for his participation. Dr. Mecide Gharibo Dr. Mecide Gharibo is an innovative hematology leader whose passion for transforming patient care extends from academic clinical expertise at Rutgers Cancer Institute to launching breakthrough therapies as Global Head of Hematology at Bristol Myers Squibb. Renowned for advancing life-saving treatments and optimizing patient access, Dr. Gharibo’s clinical excellence and senior pharmaceutical leadership have fueled medical innovation and set new standards for care through a proven record of successful therapy approvals. Dr. Gharibo is an employee of BMS.
Get DoctoRx Unscripted summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Podcasts in similar categories.
Hidden Brain
Explores human behavior and the unconscious patterns that shape our decisions, relationships, and society through science and storytelling.
Something You Should Know
Explores practical wisdom and expert insights to help listeners improve their lives, careers, and relationships.
Inside AsembleAI: DeepTech, AI & Science
Experts discuss AI's impact on business, product development, and leadership with researchers, founders, and executives.
Huberman Lab
Explores neuroscience and science-based tools for understanding and improving brain function, behavior, and health.
Big Ideas Lab
Inside Lawrence Livermore National Laboratory, uncover breakthroughs in science and technology shaping the future.
The Great Simplification with Nate Hagens
Discussions with experts on energy, ecology, economics, and human behavior to understand the systemic challenges facing civilization.
The Jordan B. Peterson Podcast
Explores how values, religion, and culture shape individuals and society through interviews and lectures.
Gastropod
Explores the science and history behind food and farming, from ancient feasts to modern aquaculture and everything in between.
About DoctoRx Unscripted
Welcome to DoctoRx Unscripted — where doctors shaping the next chapter of patient care come together for raw, real, and rigorously scientific conversations at the heart of medicine. Hosted by Dr. Tania Small, SVP of Global Medical Affairs — a physician who has dedicated her career to turning breakthrough science into real-world patient impact. In each episode, Dr. Small sits down with the world’s leading minds in medicine to dive into the breakthroughs, surface the unspoken realities, and tackle the real-world challenges shaping tomorrow’s standard of care. No soundbites. No scripts. Just evidence-based, peer-to-peer conversations that challenge thinking, ignite innovation, and equip you with insights to transform your own practice. So whether you’re in the clinic, the lab, or the boardroom — join us to rewrite patient care. Unscripted. Unfiltered. Unapologetic.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from DoctoRx Unscripted in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's DoctoRx Unscripted daily summary?
It's a free AI-powered email that summarizes new episodes of DoctoRx Unscripted as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the DoctoRx Unscripted podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official DoctoRx Unscripted product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Bristol Myers Squibb.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does DoctoRx Unscripted release new episodes?
DoctoRx Unscripted publishes monthly. Our AI generates a summary within hours of each new episode.
What topics does DoctoRx Unscripted cover?
DoctoRx Unscripted covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting DoctoRx Unscripted summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.